- You can view the full Stryker Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Jim Cramer says the earnings results we get this week will determine where stocks are headed for the rest of the quarter.
The fluorescence imaging technology company has agreed to sell to Stryker for $11.75 per share.